Literature DB >> 7111676

The detection of renovascular hypertension: a study of 490 patients by renal angiography.

J S Horvath, R C Waugh, D J Tiller, G G Duggin.   

Abstract

Four hundred and ninety patients with hypertension were studied to determine those clinical characteristics or simple investigations that predict the presence of operable renal artery stenosis on renal angiography. One hundred and fifty two of the 490 patients were below the age of 40, had a good response to treatment, a normal physical examination, normal renal function, and normal intravenous pyelogram. Only one of the 152 patients had an operable renal artery lesion. Of the remaining 338 patients, 168 had a normal angiograms, 50 had surgically correctable renal artery stenosis, 75 had renal artery narrowing of less than 70 per cent and 45 patients had significant parenchymal renal disease. Abnormal renal angiograms were found significantly (p less than 0.05) more often in patients with poor control of blood pressure, impaired renal function or a history of antipyretic analgesic abuse. Our experience in hypertensive patients suggests that renal arteriography is unlikely to provide useful information in patients under 40 years old, but may well demonstrate a remediable abnormality in older patients with poor control of hypertension associated with a history of antipyretic analgesic abuse and/or impaired renal function.

Entities:  

Mesh:

Year:  1982        PMID: 7111676

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  3 in total

Review 1.  Indications for renal artery surgery: a review.

Authors:  J S Horvath; D J Tiller
Journal:  J R Soc Med       Date:  1984-03       Impact factor: 5.344

Review 2.  Clinical practice. Renal-artery stenosis.

Authors:  Lance D Dworkin; Christopher J Cooper
Journal:  N Engl J Med       Date:  2009-11-12       Impact factor: 91.245

Review 3.  ACE inhibitors in elderly patients with hypertension. Special considerations.

Authors:  M Ravid; D Ravid
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.